Abstract
Study Objectives: The rise in obesity has been paralleled by a decline in sleep duration in epidemiological studies. However, the potential mechanisms linking energy balance and the sleep/wake cycle are not well understood. We aimed to examine the effects of manipulating energy balance on the sleep/wake cycle. Methods: Twelve healthy normal weight men were housed in a clinical research facility and studied at three time points: baseline, after energy balance was disrupted by 2 days of caloric restriction to 10% of energy requirements, and after energy balance was restored by 2 days of ad libitum/free feeding. Sleep architecture, duration of sleep stages, and sleep-associated respiratory parameters were measured by polysomnography. Results: Two days of caloric restriction significantly increased the duration of deep (stage 4) sleep (16.8% to 21.7% of total sleep time; P = 0.03); an effect which was entirely reversed upon free feeding (P = 0.01). Although the apnea-hypopnea index stayed within the reference range (< 5 events per hour), it decreased significantly from caloric restriction to free feeding (P = 0.03). Caloric restriction was associated with a marked fall in leptin (P < 0.001) and insulin levels (P = 0.002). The fall in orexin levels from baseline to caloric restriction correlated positively with duration of stage 4 sleep (Spearman rho = 0.83, P = 0.01) and negatively with the number of awakenings in caloric restriction (Spearman rho = -0.79, P = 0.01). Conclusions: We demonstrate that changes in energy homeostasis directly and reversibly impact on the sleep/wake cycle. These findings provide a mechanistic framework for investigating the association between sleep duration and obesity risk.
| Original language | English |
|---|---|
| Journal | Sleep |
| Volume | 39 |
| Issue number | 9 |
| Pages (from-to) | 1691-1700 |
| Number of pages | 10 |
| ISSN | 0161-8105 |
| DOIs | |
| Publication status | Published - 01.09.2016 |
Funding
This was not an industry supported study. This work was supported by the Wellcome Trust (to Dr. van der Klaauw and Dr. Farooqi), the National Institute for Health Research Cambridge Biomedical Research Centre, the European Research Council, the Bernard Wolfe Health Neuroscience Fund (all to Dr. Farooqi), the Swiss National Science Foundation (PBLAP3-145870, P3SMP3-155318, to Dr. Collet), the European Society of Endocrinology (IESP grant, to Dr. Schmid) and the German Research Foundation (TR-SFB 654, B01, to Dr. Schmid). This work was supported by the NeuroFAST consortium which is funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009. The authors have indicated no financial conflicts of interest.
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)